TECH
BIO-TECHNE Corp
Company overview
- Market capitalization
- $11.37B
- Employees
- 3,000
- Latest publication
- 2026-09-29
About BIO-TECHNE Corp
develop, manufacture and sell life science reagents, instruments and services
Financial statements
Income Quarterly
| Metric | Q4 20262026-06-30 · USD | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 321,191,000USD | 311,415,000USD | 295,877,000USD | 286,555,000USD | 316,181,000USD | 297,031,000USD | 289,458,000USD | 306,099,000USD |
| Cost Of Revenue | 109,797,000USD | 103,127,000USD | 104,600,000USD | 98,443,000USD | 101,625,000USD | 103,145,000USD | 106,441,000USD | 102,751,000USD |
| Research Development | 23,945,000USD | 23,455,000USD | 23,125,000USD | 24,241,000USD | 24,579,000USD | 25,016,000USD | 23,869,000USD | 23,989,000USD |
| Selling General Administrative | 113,172,000USD | 109,338,000USD | 113,691,000USD | 116,213,000USD | 151,269,000USD | 121,451,000USD | 119,161,000USD | 63,987,000USD |
| Total Operating Expenses | 137,117,000USD | 132,793,000USD | 136,816,000USD | 140,454,000USD | 175,848,000USD | 146,467,000USD | 143,030,000USD | 157,525,000USD |
| Operating Income | 74,277,000USD | 75,495,000USD | 54,461,000USD | 47,658,000USD | 38,708,000USD | 47,419,000USD | 39,987,000USD | 45,823,000USD |
| Income Before Tax | 70,681,000USD | 71,225,000USD | 50,784,000USD | 47,991,000USD | 38,274,000USD | 42,876,000USD | 40,171,000USD | 41,661,000USD |
| Net Income | 54,622,000USD | 51,057,000USD | 38,009,000USD | 38,185,000USD | 22,588,000USD | 34,890,000USD | 33,600,000USD | 40,588,000USD |
| Gross Profit | — | 208,288,000USD | 191,277,000USD | 188,112,000USD | 214,556,000USD | 193,886,000USD | 183,017,000USD | 203,348,000USD |
| Interest Income | — | 981,000USD | 897,000USD | 971,000USD | 1,026,000USD | 1,348,000USD | 926,000USD | 905,000USD |
| Interest Expense | — | 3,222,000USD | 2,171,000USD | 2,934,000USD | 2,007,000USD | 2,148,000USD | 2,176,000USD | 2,509,000USD |
| Net Interest Income | — | -1,421,000USD | -1,274,000USD | -1,963,000USD | -981,000USD | -800,000USD | -1,250,000USD | -1,604,000USD |
| Income Tax Expense | — | 20,178,000USD | 12,775,000USD | 9,806,000USD | 15,686,000USD | 7,986,000USD | 6,571,000USD | 1,073,000USD |
| Tax Provision | — | 20,178,000USD | 12,775,000USD | 9,806,000USD | 15,686,000USD | 7,986,000USD | 6,571,000USD | 1,073,000USD |
| Net Income From Continuing Ops | — | 51,047,000USD | 38,009,000USD | 38,185,000USD | 22,588,000USD | 34,890,000USD | 33,600,000USD | 40,588,000USD |
| Ebit | — | 74,447,000USD | 52,955,000USD | 50,925,000USD | 40,281,000USD | 45,024,000USD | 42,347,000USD | 44,170,000USD |
| Ebitda | — | 98,616,000USD | 77,664,000USD | 75,265,000USD | 67,852,000USD | 72,108,000USD | 70,484,000USD | 72,227,000USD |
| Depreciation And Amortization | — | 24,169,000USD | 24,709,000USD | 24,340,000USD | 27,571,000USD | 27,084,000USD | 28,137,000USD | 28,057,000USD |
| Reconciled Depreciation | — | 24,169,000USD | 24,709,000USD | 24,340,000USD | 27,571,000USD | 27,084,000USD | 28,137,000USD | 28,057,000USD |
| Total Other Income Expense Net | — | -4,270,000USD | -3,677,000USD | 333,000USD | -434,000USD | -4,543,000USD | 184,000USD | -4,162,000USD |
| Unclassified Operating Expenses | — | — | — | — | — | — | — | 69,549,000USD |
| Minority Interest | — | — | — | — | — | — | — | 0USD |
| Source | DisclosurePreliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20262026-06-30 · USD | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20212021-06-30 · USD | FY 20202020-06-30 · USD | FY 20192019-06-30 · USD | FY 20182018-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,215,039,000USD | 1,219,635,000USD | 1,159,060,000USD | 1,136,702,000USD | 931,032,000USD | 738,691,000USD | 714,006,000USD | 642,993,000USD |
| Cost Of Revenue | 415,968,000USD | 429,363,000USD | 389,335,000USD | 366,887,000USD | 298,182,000USD | 255,497,000USD | 240,515,000USD | 210,850,000USD |
| Gross Profit | 799,071,000USD | 790,272,000USD | 769,725,000USD | 769,815,000USD | 632,850,000USD | 483,194,000USD | 473,491,000USD | 432,143,000USD |
| Research Development | 94,766,000USD | 99,496,000USD | 96,664,000USD | 92,493,000USD | 70,603,000USD | 65,192,000USD | 62,413,000USD | 55,329,000USD |
| Selling General Administrative | 452,415,000USD | 415,097,000USD | 393,320,000USD | 352,438,000USD | 289,924,000USD | 240,882,000USD | 236,867,000USD | 240,636,000USD |
| Total Operating Expenses | 547,181,000USD | 688,017,000USD | 563,039,000USD | 470,871,000USD | 395,554,000USD | 325,775,000USD | 326,772,000USD | 295,965,000USD |
| Operating Income | 251,890,000USD | 102,255,000USD | 206,686,000USD | 298,944,000USD | 237,296,000USD | 157,419,000USD | 125,583,000USD | 136,178,000USD |
| Total Other Income Expense Net | -11,210,000USD | -3,792,000USD | -20,997,000USD | 39,715,000USD | -89,121,000USD | 119,058,000USD | -34,704,000USD | -10,226,000USD |
| Interest Expense | 9,630,000USD | 8,509,000USD | 15,736,000USD | 11,215,000USD | 13,952,000USD | 19,197,000USD | 21,705,000USD | 10,188,000USD |
| Income Before Tax | 240,680,000USD | 98,463,000USD | 185,689,000USD | 338,659,000USD | 148,175,000USD | 276,477,000USD | 112,015,000USD | 125,952,000USD |
| Income Tax Expense | 58,818,000USD | 25,063,000USD | 17,584,000USD | 53,217,000USD | 8,590,000USD | 47,181,000USD | 15,943,000USD | 602,000USD |
| Equity Method Income Loss | 887,000USD | — | — | — | — | — | — | — |
| Net Income | 181,862,000USD | 73,400,000USD | 168,105,000USD | 285,263,000USD | 140,410,000USD | 229,296,000USD | 96,072,000USD | 125,350,000USD |
| Net Income Applicable To Common Shares | 181,840,000USD | — | — | 285,263,000USD | 140,410,000USD | 229,072,000USD | 95,967,000USD | 126,042,000USD |
| Unclassified Operating Expenses | — | 173,424,000USD | — | — | — | — | — | — |
| Interest Income | — | 3,886,000USD | 3,323,000USD | 3,410,000USD | 473,000USD | 605,000USD | 569,000USD | 409,000USD |
| Net Interest Income | — | -4,623,000USD | -12,413,000USD | -7,805,000USD | -13,479,000USD | -18,592,000USD | -21,136,000USD | -9,779,000USD |
| Tax Provision | — | 25,063,000USD | 17,584,000USD | 53,217,000USD | 8,590,000USD | 47,181,000USD | 15,943,000USD | -198,000USD |
| Net Income From Continuing Ops | — | 73,400,000USD | 168,105,000USD | 285,442,000USD | 139,585,000USD | 229,296,000USD | 96,072,000USD | 126,150,000USD |
| Ebit | — | 106,972,000USD | 201,425,000USD | 349,874,000USD | 162,127,000USD | 295,674,000USD | 133,720,000USD | 136,178,000USD |
| Ebitda | — | 216,875,000USD | 313,136,000USD | 457,112,000USD | 249,874,000USD | 378,411,000USD | 211,891,000USD | 200,641,000USD |
| Depreciation And Amortization | — | 109,903,000USD | 111,711,000USD | 107,238,000USD | 87,747,000USD | 82,737,000USD | 78,171,000USD | 64,463,000USD |
| Reconciled Depreciation | — | 109,903,000USD | 111,711,000USD | 107,238,000USD | 87,747,000USD | 82,737,000USD | 78,171,000USD | 64,463,000USD |
| Minority Interest | — | 0USD | 0USD | -179,000USD | 8,263,000USD | 8,263,000USD | 8,263,000USD | 8,263,000USD |
| Selling And Marketing Expenses | — | — | 69,549,000USD | 25,940,000USD | 35,027,000USD | 19,701,000USD | 27,492,000USD | — |
| Non Operating Income Net Other | — | — | — | 50,930,000USD | -75,169,000USD | 138,255,000USD | -12,999,000USD | -38,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q4 20262026-06-30 · USD | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 2,586,726,000USD | 2,550,601,000USD | 2,522,699,000USD | 2,526,148,000USD | 2,557,868,000USD | 2,644,259,000USD | 2,670,424,000USD | 2,736,017,000USD |
| Cash And Equivalents | 264,712,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 744,401,000USD | 688,050,000USD | 637,432,000USD | 609,507,000USD | 608,300,000USD | 627,240,000USD | 634,640,000USD | 648,567,000USD |
| Other Current Assets | 67,360,000USD | 59,140,000USD | 74,492,000USD | 77,460,000USD | 49,792,000USD | 58,347,000USD | 50,778,000USD | 52,298,000USD |
| Other Non Current Assets | 264,336,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 478,505,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 163,700,000USD | 153,278,000USD | 140,426,000USD | 144,545,000USD | 175,849,000USD | 169,204,000USD | 161,256,000USD | 142,128,000USD |
| Other Current Liabilities | 4,025,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 21,345,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 2,108,221,000USD | 2,085,304,000USD | 2,010,989,000USD | 1,965,814,000USD | 1,918,808,000USD | 2,018,025,000USD | 2,078,492,000USD | 2,138,650,000USD |
| Total Equity Including Noncontrolling Interest | 2,108,221,000USD | — | — | — | — | — | — | — |
| Long Term Debt | 200,000,000USD | 200,000,000USD | 260,000,000USD | 300,000,000USD | 346,000,000USD | 330,000,000USD | 300,000,000USD | 300,000,000USD |
| Deferred Revenue | 36,072,000USD | — | — | — | — | — | — | — |
| Net Receivables | 216,585,000USD | 217,916,000USD | 184,614,000USD | 183,897,000USD | 206,876,000USD | 237,140,000USD | 217,940,000USD | 223,688,000USD |
| Inventory | 195,744,000USD | 201,175,000USD | 205,447,000USD | 203,188,000USD | 189,446,000USD | 191,083,000USD | 188,373,000USD | 185,041,000USD |
| Property Plant Equipment Net | 299,169,000USD | 301,306,000USD | 302,632,000USD | 311,059,000USD | 319,118,000USD | 335,766,000USD | 335,136,000USD | 343,160,000USD |
| Goodwill | 975,355,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 303,465,000USD | 319,074,000USD | 334,990,000USD | 350,107,000USD | 365,599,000USD | 443,699,000USD | 461,051,000USD | 486,004,000USD |
| Accounts Payable | 26,699,000USD | 23,490,000USD | 26,269,000USD | 30,157,000USD | 25,311,000USD | 31,644,000USD | 33,120,000USD | 31,559,000USD |
| Short Term Debt | 14,935,000USD | 14,181,000USD | 13,710,000USD | 13,771,000USD | 14,098,000USD | 14,049,000USD | 13,511,000USD | 13,485,000USD |
| Common Stock | 1,561,000USD | 1,565,000USD | 1,559,000USD | 1,557,000USD | 1,550,000USD | 1,568,000USD | 1,579,000USD | 1,589,000USD |
| Retained Earnings | 1,144,188,000USD | 1,145,192,000USD | 1,106,819,000USD | 1,082,534,000USD | 1,066,049,000USD | 1,196,385,000USD | 1,286,699,000USD | 1,341,175,000USD |
| Accumulated Other Comprehensive Income | -70,580,000USD | -66,855,999USD | -62,344,000USD | -64,395,000USD | -59,880,000USD | -82,052,000USD | -85,650,000USD | -60,087,000USD |
| Short Long Term Debt | 200,000,000USD | — | — | — | — | — | — | — |
| Total Liab | — | 465,297,000USD | 511,710,000USD | 560,334,000USD | 639,060,000USD | 626,234,000USD | 591,932,000USD | 597,367,000USD |
| Other Current Liab | — | 74,203,000USD | 66,941,000USD | 67,324,000USD | 93,099,000USD | 87,614,000USD | 83,769,000USD | 67,334,000USD |
| Capital Stock | — | 1,565,000USD | 1,559,000USD | 1,557,000USD | 1,550,000USD | 1,568,000USD | 1,579,000USD | 1,589,000USD |
| Good Will | — | 977,800,000USD | 980,561,000USD | 978,912,000USD | 980,935,000USD | 968,612,000USD | 964,607,000USD | 982,585,000USD |
| Cash | — | 209,819,000USD | 172,879,000USD | 144,962,000USD | 162,186,000USD | 140,670,000USD | 177,549,000USD | 187,540,000USD |
| Cash And Short Term Investments | — | 209,819,000USD | 172,879,000USD | 144,962,000USD | 162,186,000USD | 140,670,000USD | 177,549,000USD | 187,540,000USD |
| Current Deferred Revenue | — | 38,433,000USD | 31,030,000USD | 30,445,000USD | 32,571,000USD | 32,269,000USD | 27,715,000USD | 26,614,000USD |
| Net Debt | — | 80,503,000USD | 178,016,000USD | 249,511,000USD | 281,872,000USD | 282,829,000USD | 217,578,000USD | 211,378,000USD |
| Short Long Term Debt Total | — | 290,322,000USD | 350,895,000USD | 394,473,000USD | 444,058,000USD | 423,499,000USD | 395,127,000USD | 398,918,000USD |
| Long Term Investments | — | 246,028,000USD | 250,036,000USD | 258,607,000USD | 250,983,000USD | 254,515,000USD | 256,354,000USD | 256,308,000USD |
| Property Plant Equipment Gross | — | 602,123,000USD | 595,741,000USD | 600,040,000USD | 605,249,000USD | 614,557,000USD | 605,449,000USD | 608,422,000USD |
| Common Stock Shares Outstanding | — | 156,943,000shares | 156,999,000shares | 156,362,000shares | 155,757,000shares | 158,944,000shares | 160,626,000shares | 161,115,000shares |
| Non Current Assets Total | — | 1,862,551,000USD | 1,885,267,000USD | 1,916,641,000USD | 1,949,568,000USD | 2,017,064,000USD | 2,035,784,000USD | 2,087,450,000USD |
| Non Current Liabilities Total | — | 312,019,000USD | 371,284,000USD | 415,789,000USD | 463,211,000USD | 457,030,000USD | 430,676,000USD | 455,239,000USD |
| Non Current Liabilities Other | — | 21,668,000USD | 23,078,000USD | 23,814,000USD | 27,082,000USD | 15,656,000USD | 11,337,000USD | 19,789,000USD |
| Non Currrent Assets Other | — | 10,224,000USD | 17,048,000USD | 10,212,000USD | 22,626,000USD | 14,472,000USD | 18,636,000USD | 19,393,000USD |
| Net Working Capital | — | 534,772,000USD | 497,006,000USD | 464,962,000USD | 432,451,000USD | 458,036,000USD | 473,384,000USD | 506,439,000USD |
| Unclassified Current Liabilities | — | 2,971,000USD | 2,476,000USD | 2,848,000USD | 10,770,000USD | 3,628,000USD | 3,141,000USD | 3,136,000USD |
| Unclassified Non Current Liabilities | — | 90,351,000USD | 88,206,000USD | 91,975,000USD | 90,129,000USD | 111,374,000USD | 119,339,000USD | 135,450,000USD |
| Unclassified Equity | — | 1,003,837,999USD | 963,396,000USD | 944,561,000USD | 909,539,000USD | 900,556,000USD | 874,285,000USD | 854,384,000USD |
| Short Term Investments | — | — | — | — | 0USD | 0USD | 0USD | 0USD |
| Other Assets | — | — | — | — | — | -45,000USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20262026-06-30 · USD | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD | FY 20202020-06-30 · USD | FY 20192019-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Long term debt obligations | 200,000,000USD | — | — | — | — | — | — | — |
| Trade accounts payable | 26,699,000USD | — | — | — | — | — | — | — |
| Deferred income taxes | 19,308,000USD | — | — | — | — | — | — | — |
| Contract liabilities | 36,072,000USD | — | — | — | — | — | — | — |
| Right of use assets | 67,333,000USD | — | — | — | — | — | — | — |
| Intangible assets, net | 303,465,000USD | — | — | — | — | — | — | — |
| Total current assets | 744,401,000USD | — | — | — | — | — | — | — |
| Other current assets | 67,360,000USD | — | — | — | — | — | — | — |
| Inventories | 195,744,000USD | — | — | — | — | — | — | — |
| Cash and cash equivalents | 264,712,000USD | — | — | — | — | — | — | — |
| Property and equipment, net | 231,836,000USD | — | — | — | — | — | — | — |
| Goodwill | 975,355,000USD | — | — | — | — | — | — | — |
| Total current liabilities | 163,700,000USD | — | — | — | — | — | — | — |
| Operating lease liabilities current | 14,935,000USD | — | — | — | — | — | — | — |
| Other current liabilities | 4,025,000USD | — | — | — | — | — | — | — |
| Other assets | 264,336,000USD | — | — | — | — | — | — | — |
| Accumulated other comprehensive loss | -70,580,000USD | — | — | — | — | — | — | — |
| Total liabilities and shareholders’ equity | 2,586,726,000USD | — | — | — | — | — | — | — |
| Common stock, par value $.01 per share; authorized 400,000,000; issued and outstanding 156,095,113 and 154,972,196 respectively | 1,561USD/share | — | — | — | — | — | — | — |
| Income taxes payable | 3,593,000USD | — | — | — | — | — | — | — |
| Operating lease liabilities | 74,152,000USD | — | — | — | — | — | — | — |
| Additional paid in capital | 1,033,052,000USD | — | — | — | — | — | — | — |
| Accrued expenses | 20,458,000USD | — | — | — | — | — | — | — |
| Total shareholders’ equity | 2,108,221,000USD | — | — | — | — | — | — | — |
| Retained earnings | 1,144,188,000USD | — | — | — | — | — | — | — |
| Salaries, wages and related accruals | 57,918,000USD | — | — | — | — | — | — | — |
| Other long term liabilities | 21,345,000USD | — | — | — | — | — | — | — |
| Accounts receivable, less allowances of $4,644 and $4,215, respectively | 216,585,000USD | — | — | — | — | — | — | — |
| Total assets | 2,586,726,000USD | — | — | — | — | — | — | — |
| Total Assets | — | 2,557,868,000USD | 2,703,867,000USD | 2,638,692,000USD | 2,294,805,000USD | 2,262,957,000USD | 2,027,589,000USD | 1,884,410,000USD |
| Intangible Assets | — | 365,599,000USD | 507,081,000USD | 534,645,000USD | 531,522,000USD | 615,968,000USD | 516,545,000USD | 579,429,000USD |
| Other Current Assets | — | 49,792,000USD | 43,431,000USD | 27,066,000USD | 22,856,000USD | 16,919,000USD | 24,341,000USD | 18,058,000USD |
| Total Liab | — | 639,060,000USD | 635,017,000USD | 672,176,000USD | 593,794,000USD | 691,723,000USD | 646,397,000USD | 718,821,000USD |
| Total Stockholder Equity | — | 1,918,808,000USD | 2,068,850,000USD | 1,966,516,000USD | 1,701,770,000USD | 1,562,971,000USD | 1,381,192,000USD | 1,165,589,000USD |
| Other Current Liab | — | 93,099,000USD | 76,855,000USD | 56,540,000USD | 81,082,000USD | 74,467,000USD | 46,118,000USD | 58,427,000USD |
| Common Stock | — | 1,550,000USD | 1,582,000USD | 1,576,000USD | 1,566,000USD | 390,000USD | 385,000USD | 379,000USD |
| Capital Stock | — | 1,550,000USD | 1,582,000USD | 1,576,000USD | 392,000USD | 390,000USD | 385,000USD | 379,000USD |
| Retained Earnings | — | 1,066,049,000USD | 1,325,247,000USD | 1,309,461,000USD | 1,122,937,000USD | 1,085,461,000USD | 1,057,470,000USD | 931,934,000USD |
| Good Will | — | 980,935,000USD | 972,663,000USD | 872,737,000USD | 822,101,000USD | 843,067,000USD | 728,308,000USD | 732,667,000USD |
| Cash | — | 162,186,000USD | 151,791,000USD | 180,571,000USD | 172,567,000USD | 199,091,000USD | 146,625,000USD | 100,886,000USD |
| Cash And Short Term Investments | — | 162,186,000USD | 152,863,000USD | 204,310,000USD | 247,029,000USD | 231,554,000USD | 270,893,000USD | 166,033,000USD |
| Total Current Assets | — | 608,300,000USD | 617,419,000USD | 621,482,000USD | 605,556,000USD | 510,606,000USD | 520,920,000USD | 412,607,000USD |
| Total Current Liabilities | — | 175,849,000USD | 159,379,000USD | 128,509,000USD | 176,018,000USD | 152,284,000USD | 106,668,000USD | 101,985,000USD |
| Current Deferred Revenue | — | 32,571,000USD | 27,930,000USD | 23,069,000USD | 23,406,000USD | 18,995,000USD | 13,049,000USD | 9,084,000USD |
| Net Debt | — | 281,872,000USD | 267,747,000USD | 274,394,000USD | 153,404,000USD | 221,463,000USD | 286,901,000USD | 404,274,000USD |
| Short Term Debt | — | 14,098,000USD | 12,920,000USD | 11,199,000USD | 24,428,000USD | 24,102,000USD | 22,035,000USD | 12,500,000USD |
| Short Long Term Debt Total | — | 444,058,000USD | 419,538,000USD | 454,965,000USD | 325,971,000USD | 420,554,000USD | 433,526,000USD | 505,160,000USD |
| Long Term Debt | — | 346,000,000USD | 319,000,000USD | 350,000,000USD | 243,410,000USD | 328,827,000USD | 344,243,000USD | 492,660,000USD |
| Long Term Investments | — | 250,983,000USD | 242,337,000USD | 255,857,000USD | 25,000,000USD | — | — | — |
| Short Term Investments | — | 0USD | 1,072,000USD | 23,739,000USD | 74,462,000USD | 32,463,000USD | 124,268,000USD | 65,147,000USD |
| Net Receivables | — | 206,876,000USD | 241,394,000USD | 218,468,000USD | 194,548,000USD | 145,385,000USD | 122,534,000USD | 137,466,000USD |
| Inventory | — | 189,446,000USD | 179,731,000USD | 171,638,000USD | 141,123,000USD | 116,748,000USD | 103,152,000USD | 91,050,000USD |
| Accounts Payable | — | 25,311,000USD | 37,968,000USD | 25,679,000USD | 33,865,000USD | 29,384,000USD | 23,090,000USD | 16,210,000USD |
| Property Plant Equipment Net | — | 319,118,000USD | 342,439,000USD | 324,526,000USD | 288,798,000USD | 281,741,000USD | 248,294,000USD | 154,039,000USD |
| Property Plant Equipment Gross | — | 605,249,000USD | 598,995,000USD | 324,526,000USD | 288,798,000USD | 281,741,000USD | 248,294,000USD | 154,039,000USD |
| Accumulated Other Comprehensive Income | — | -59,880,000USD | -78,316,000USD | -66,064,000USD | -75,200,000USD | -57,291,000USD | -97,199,000USD | -83,521,000USD |
| Common Stock Shares Outstanding | — | 159,717,000shares | 160,774,000shares | 161,855,000shares | 164,116,000shares | 161,932,000shares | 157,604,000shares | 155,568,000shares |
| Non Current Assets Total | — | 1,949,568,000USD | 2,086,448,000USD | 2,017,210,000USD | 1,689,249,000USD | 1,752,351,000USD | 1,506,669,000USD | 1,471,803,000USD |
| Non Current Liabilities Total | — | 463,211,000USD | 475,638,000USD | 543,667,000USD | 417,776,000USD | 539,439,000USD | 539,729,000USD | 616,836,000USD |
| Non Current Liabilities Other | — | 27,082,000USD | 13,157,000USD | 10,919,000USD | 12,239,000USD | 24,462,000USD | 26,949,000USD | 25,222,000USD |
| Non Currrent Assets Other | — | 22,626,000USD | 21,928,000USD | 29,445,000USD | 46,828,000USD | 11,300,000USD | 13,522,000USD | 5,668,000USD |
| Net Working Capital | — | 432,451,000USD | 458,040,000USD | 492,973,000USD | 429,538,000USD | 358,322,000USD | 414,252,000USD | 310,622,000USD |
| Unclassified Current Liabilities | — | 10,770,000USD | 3,706,000USD | 12,022,000USD | — | -7,164,000USD | -10,124,000USD | -6,736,000USD |
| Unclassified Non Current Liabilities | — | 90,129,000USD | 143,481,000USD | -6,135,000USD | -53,100,000USD | -49,962,000USD | -43,460,000USD | -102,518,000USD |
| Unclassified Equity | — | 909,539,000USD | 818,755,000USD | 719,967,000USD | 652,075,000USD | 534,021,000USD | 420,151,000USD | 316,418,000USD |
| Deferred Long Term Liab | — | — | — | 88,982,000USD | 98,994,000USD | 93,125,000USD | 101,090,000USD | 89,754,000USD |
| Other Liab | — | — | — | 99,901,000USD | 116,233,000USD | 142,987,000USD | 110,907,000USD | 111,718,000USD |
| Other Assets | — | — | — | 12,588,000USD | 46,828,000USD | 11,575,000USD | 13,522,000USD | 5,668,000USD |
| Net Tangible Assets | — | — | — | 652,900,000USD | 347,388,000USD | 112,199,000USD | 136,339,000USD | -146,507,000USD |
| Short Long Term Debt | — | — | — | — | 12,500,000USD | 12,500,000USD | 12,500,000USD | 12,500,000USD |
| Unclassified Non Current Assets | — | — | — | — | -71,828,000USD | — | — | — |
| Source | DisclosureVerified | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20262026-06-30 · USD | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD | FY 20202020-06-30 · USD | FY 20192019-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Proceeds from sale of assets held for sale | 4,617,000USD | — | — | — | — | — | — | — |
| Loss on investments | -5,862,000USD | — | — | — | — | — | — | — |
| Trade accounts and other receivables, net | -10,793,000USD | — | — | — | — | — | — | — |
| Prepaid expenses | -5,264,000USD | — | — | — | — | — | — | — |
| Net cash used in financing activities | -169,114,000USD | — | — | — | — | — | — | — |
| Leases, net | -2,983,000USD | — | — | — | — | — | — | — |
| Depreciation and amortization | 97,359,000USD | — | — | — | — | — | — | — |
| Stock based compensation expense | 41,365,000USD | — | — | — | — | — | — | — |
| Repayments of long term debt | -146,000,000USD | — | — | — | — | — | — | — |
| Repurchases of common stock | -41,675,000USD | — | — | — | — | — | — | — |
| Cash and cash equivalents at end of period | 264,712,000USD | — | — | — | — | — | — | — |
| Net cash provided by operating activities | 292,073,000USD | — | — | — | — | — | — | — |
| Cash dividends | -49,916,000USD | — | — | — | — | — | — | — |
| Trade accounts payable, accrued expenses, contract liabilities, and other | 3,180,000USD | — | — | — | — | — | — | — |
| Effect of exchange rate changes on cash and cash equivalents | -2,243,000USD | — | — | — | — | — | — | — |
| Inventories | -8,232,000USD | — | — | — | — | — | — | — |
| Asset impairment restructuring | 3,914,000USD | — | — | — | — | — | — | — |
| Taxes paid on RSUs and net share settlements | -12,141,000USD | — | — | — | — | — | — | — |
| Proceeds from stock option exercises | 80,618,000USD | — | — | — | — | — | — | — |
| Deferred income taxes | 13,196,000USD | — | — | — | — | — | — | — |
| Other operating activity | 477,000USD | — | — | — | — | — | — | — |
| Net earnings | 181,862,000USD | — | — | — | — | — | — | — |
| Income taxes payable | -23,051,000USD | — | — | — | — | — | — | — |
| Net cash used in investing activities | -18,190,000USD | — | — | — | — | — | — | — |
| (Recovery) Impairment of assets held for sale | -6,789,000USD | — | — | — | — | — | — | — |
| Additions to property and equipment | -28,850,000USD | — | — | — | — | — | — | — |
| Net change in cash and cash equivalents | 102,526,000USD | — | — | — | — | — | — | — |
| Distributions from Wilson Wolf | 6,043,000USD | — | — | — | — | — | — | — |
| (Gain) Loss on equity method investment | -887,000USD | — | — | — | — | — | — | — |
| Salaries, wages and related accruals | -7,671,000USD | — | — | — | — | — | — | — |
| Net Income | — | 73,400,000USD | 168,072,000USD | 285,442,000USD | 263,099,000USD | 139,585,000USD | 229,296,000USD | 96,072,000USD |
| Depreciation | — | 109,903,000USD | 111,711,000USD | 107,238,000USD | 101,069,000USD | 87,747,000USD | 82,737,000USD | 78,171,000USD |
| Stock Based Compensation | — | 40,833,000USD | 38,042,000USD | 39,230,000USD | 42,183,000USD | 48,982,000USD | 32,367,000USD | 32,280,000USD |
| Other Non Cash Items | — | 102,988,000USD | 30,709,000USD | -99,763,000USD | -18,378,000USD | 74,018,000USD | -147,067,000USD | 16,429,000USD |
| Change To Account Receivables | — | 42,601,000USD | -31,132,000USD | -20,867,000USD | -57,596,000USD | -15,549,000USD | 6,556,000USD | -2,700,000USD |
| Change To Inventory | — | -18,144,000USD | -14,215,000USD | 400,000USD | -32,007,000USD | -7,140,000USD | -14,861,000USD | -13,647,000USD |
| Change In Working Capital | — | 11,539,000USD | -10,106,000USD | -48,187,000USD | -69,517,000USD | 29,263,000USD | -5,246,000USD | -27,751,000USD |
| Total Cash From Operating Activities | — | 287,556,000USD | 298,981,000USD | 254,393,000USD | 325,272,000USD | 352,164,000USD | 205,217,000USD | 181,619,000USD |
| Capital Expenditures | — | -31,006,000USD | -62,877,000USD | -38,244,000USD | -44,908,000USD | -44,301,000USD | -51,744,000USD | -25,411,000USD |
| Free Cash Flow | — | 256,550,000USD | 236,104,000USD | 216,149,000USD | 280,364,000USD | 307,863,000USD | 153,473,000USD | 156,208,000USD |
| Investments | — | -35,183,000USD | -203,030,000USD | -265,649,000USD | -96,851,000USD | -243,516,000USD | 76,933,000USD | -21,896,000USD |
| Total Cashflows From Investing Activities | — | -35,183,000USD | -203,030,000USD | -265,649,000USD | -96,851,000USD | -243,516,000USD | 27,095,000USD | -336,799,000USD |
| Net Borrowings | — | 27,000,000USD | -31,000,000USD | 94,000,000USD | -85,500,000USD | -15,500,000USD | -148,500,000USD | 166,500,000USD |
| Total Cash From Financing Activities | — | -253,905,000USD | -122,398,000USD | 22,616,000USD | -242,853,000USD | -62,551,000USD | -183,802,000USD | 134,384,000USD |
| Dividends Paid | — | -50,391,000USD | -50,419,000USD | -50,285,000USD | -50,185,000USD | -49,622,000USD | -48,902,000USD | -48,364,000USD |
| Sale Purchase Of Stock | — | -275,731,000USD | -80,042,000USD | -19,562,000USD | -160,950,000USD | -43,178,000USD | -50,112,000USD | -15,405,000USD |
| Change In Cash | — | 10,395,000USD | -28,780,000USD | 8,004,000USD | -26,524,000USD | 52,466,000USD | 45,739,000USD | -21,104,000USD |
| Begin Period Cash Flow | — | 151,791,000USD | 180,571,000USD | 172,567,000USD | 199,091,000USD | 146,625,000USD | 100,886,000USD | 121,990,000USD |
| End Period Cash Flow | — | 162,186,000USD | 151,791,000USD | 180,571,000USD | 172,567,000USD | 199,091,000USD | 146,625,000USD | 100,886,000USD |
| Other Cashflows From Investing Activities | — | 15,264,000USD | 6,997,000USD | -27,965,000USD | -51,943,000USD | -225,908,000USD | 1,906,000USD | -21,896,000USD |
| Other Cashflows From Financing Activities | — | 45,217,000USD | 39,063,000USD | 92,463,000USD | 143,782,000USD | -19,343,000USD | -7,271,000USD | 31,653,000USD |
| Unclassified Operating Cash Flow | — | -51,107,000USD | -39,447,000USD | -29,567,000USD | 6,816,000USD | -27,431,000USD | 13,130,000USD | -13,582,000USD |
| Unclassified Investing Cash Flow | — | 15,742,000USD | 55,880,000USD | 66,209,000USD | 96,851,000USD | 270,209,000USD | — | -267,596,000USD |
| Change To Liabilities | — | — | — | -34,958,000USD | 12,741,000USD | 19,091,000USD | 5,664,000USD | 1,594,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 11,360,000USD | -14,432,000USD | 46,097,000USD | 48,510,000USD | -21,104,000USD |
| Unclassified Financing Cash Flow | — | — | — | -94,000,000USD | -90,000,000USD | 65,092,000USD | 70,983,000USD | — |
| Exchange Rate Changes | — | — | — | — | — | — | — | -308,000USD |
| Source | DisclosureVerified | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 51,047,000USD | 38,009,000USD | 38,185,000USD | -17,678,000USD | 22,588,000USD | 34,887,000USD | 33,600,000USD | 40,578,000USD |
| Depreciation | 24,169,000USD | 24,709,000USD | 24,340,000USD | 27,111,000USD | 27,571,000USD | 27,084,000USD | 28,137,000USD | 28,057,000USD |
| Stock Based Compensation | 10,495,000USD | 13,958,000USD | 11,682,000USD | 4,550,000USD | 11,391,000USD | 14,708,000USD | 10,184,000USD | 7,063,000USD |
| Other Non Cash Items | 2,229,000USD | -37,042,000USD | -9,048,000USD | 94,930,000USD | -2,533,000USD | 18,257,000USD | 7,045,000USD | 19,585,000USD |
| Change To Account Receivables | -31,256,000USD | -22,392,000USD | 22,392,000USD | 45,242,000USD | -15,669,000USD | -623,000USD | 21,563,000USD | -17,922,000USD |
| Change To Inventory | 3,431,000USD | 14,002,000USD | -14,002,000USD | -6,604,000USD | 173,000USD | -8,908,000USD | 188,000USD | -4,616,000USD |
| Change In Working Capital | -4,121,000USD | 42,849,000USD | -42,849,000USD | 21,570,000USD | -12,489,000USD | 12,195,000USD | -9,737,000USD | -10,236,000USD |
| Total Cash From Operating Activities | 86,661,000USD | 82,411,000USD | 27,585,000USD | 98,201,000USD | 41,120,000USD | 84,346,000USD | 63,889,000USD | 75,496,000USD |
| Capital Expenditures | -9,086,000USD | -5,921,000USD | -5,363,000USD | -4,890,000USD | -10,123,000USD | -6,821,000USD | -9,172,000USD | -17,980,000USD |
| Free Cash Flow | 77,575,000USD | 76,490,000USD | 22,222,000USD | 93,311,000USD | 30,997,000USD | 77,525,000USD | 54,717,000USD | 57,516,000USD |
| Investments | 0USD | 0USD | 605,000USD | 406,000USD | -8,873,000USD | -5,032,000USD | -21,684,000USD | -8,808,000USD |
| Total Cashflows From Investing Activities | -5,817,000USD | -5,921,000USD | 605,000USD | 406,000USD | -8,873,000USD | -5,032,000USD | -21,684,000USD | -8,808,000USD |
| Net Borrowings | -60,000,000USD | -40,000,000USD | -46,000,000USD | 16,000,000USD | 30,000,000USD | 0USD | -19,000,000USD | — |
| Total Cash From Financing Activities | -42,716,000USD | -48,986,000USD | -44,204,000USD | -90,452,000USD | -68,045,000USD | -83,837,000USD | -11,571,000USD | -60,095,000USD |
| Dividends Paid | -12,518,000USD | -12,470,000USD | -12,444,000USD | -12,387,000USD | -12,580,000USD | -12,736,000USD | -12,688,000USD | -12,627,000USD |
| Sale Purchase Of Stock | 24,000USD | -24,000USD | -24,000USD | -100,057,000USD | -100,046,000USD | -75,628,000USD | — | -402,000USD |
| Change In Cash | 36,940,000USD | 27,917,000USD | -17,224,000USD | 21,516,000USD | -36,879,000USD | -9,991,000USD | 35,749,000USD | 11,876,000USD |
| Begin Period Cash Flow | 172,879,000USD | 144,962,000USD | 162,186,000USD | 140,670,000USD | 177,549,000USD | 187,540,000USD | 151,791,000USD | 139,915,000USD |
| End Period Cash Flow | 209,819,000USD | 172,879,000USD | 144,962,000USD | 162,186,000USD | 140,670,000USD | 177,549,000USD | 187,540,000USD | 151,791,000USD |
| Other Cashflows From Investing Activities | 9,237,000USD | — | 5,968,000USD | 5,296,000USD | 1,250,000USD | 1,789,000USD | 1,403,000USD | -175,516,000USD |
| Other Cashflows From Financing Activities | -157,000USD | -1,255,000USD | 14,264,000USD | 5,992,000USD | 14,872,000USD | -1,013,000USD | -4,984,000USD | 22,934,000USD |
| Unclassified Operating Cash Flow | 2,842,000USD | — | 5,275,000USD | -32,282,000USD | -5,408,000USD | -22,785,000USD | -5,340,000USD | -9,551,000USD |
| Unclassified Investing Cash Flow | -5,968,000USD | — | — | — | 8,873,000USD | 5,032,000USD | 7,769,000USD | 193,496,000USD |
| Unclassified Financing Cash Flow | 29,935,000USD | 4,763,000USD | — | — | — | 5,540,000USD | 25,101,000USD | -70,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q3 2026Quarterly · 2026-03-31 | Geography | APACExcluding Greater China | 21,820,000 | USD | 0001104659-26-056302 |
| Q3 2026Quarterly · 2026-03-31 | Geography | China | 26,012,000 | USD | 0001104659-26-056302 |
| Q3 2026Quarterly · 2026-03-31 | Geography | EMEAExcluding UK | 73,446,000 | USD | 0001104659-26-056302 |
| Q3 2026Quarterly · 2026-03-31 | Geography | Rest of World | 7,767,000 | USD | 0001104659-26-056302 |
| Q3 2026Quarterly · 2026-03-31 | Geography | United Kingdom | 14,891,000 | USD | 0001104659-26-056302 |
| Q3 2026Quarterly · 2026-03-31 | Geography | United States | 167,479,000 | USD | 0001104659-26-056302 |
| Q3 2026Quarterly · 2026-03-31 | Product | Other | 325,000 | USD | 0001104659-26-056302 |
| Q3 2026Quarterly · 2026-03-31 | Product | Product And Services — Consumables | 257,338,000 | USD | 0001104659-26-056302 |
| Q3 2026Quarterly · 2026-03-31 | Product | Product And Services — Instruments | 27,664,000 | USD | 0001104659-26-056302 |
| Q3 2026Quarterly · 2026-03-31 | Product | Royalty | 4,967,000 | USD | 0001104659-26-056302 |
| Q3 2026Quarterly · 2026-03-31 | Product | Services | 21,446,000 | USD | 0001104659-26-056302 |
| Q3 2026Quarterly · 2026-03-31 | Segment | Diagnostics And Spatial Biology | 85,586,000 | USD | 0001104659-26-056302 |
| Q3 2026Quarterly · 2026-03-31 | Segment | Protein Sciences | 226,154,000 | USD | 0001104659-26-056302 |
| Q2 2026Quarterly · 2025-12-31 | Geography | APACExcluding Greater China | 22,742,000 | USD | 0001104659-26-010335 |
| Q2 2026Quarterly · 2025-12-31 | Geography | China | 26,351,000 | USD | 0001104659-26-010335 |
| Q2 2026Quarterly · 2025-12-31 | Geography | EMEAExcluding UK | 75,354,000 | USD | 0001104659-26-010335 |
| Q2 2026Quarterly · 2025-12-31 | Geography | Rest of World | 11,145,000 | USD | 0001104659-26-010335 |
| Q2 2026Quarterly · 2025-12-31 | Geography | United Kingdom | 13,728,000 | USD | 0001104659-26-010335 |
| Q2 2026Quarterly · 2025-12-31 | Geography | United States | 146,557,000 | USD | 0001104659-26-010335 |
| Q2 2026Quarterly · 2025-12-31 | Product | Other | 387,000 | USD | 0001104659-26-010335 |
| Q2 2026Quarterly · 2025-12-31 | Product | Product And Services — Consumables | 235,443,000 | USD | 0001104659-26-010335 |
| Q2 2026Quarterly · 2025-12-31 | Product | Product And Services — Instruments | 29,605,000 | USD | 0001104659-26-010335 |
| Q2 2026Quarterly · 2025-12-31 | Product | Royalty | 8,513,000 | USD | 0001104659-26-010335 |
| Q2 2026Quarterly · 2025-12-31 | Product | Services | 22,316,000 | USD | 0001104659-26-010335 |
| Q2 2026Quarterly · 2025-12-31 | Segment | Diagnostics And Spatial Biology | 81,180,000 | USD | 0001104659-26-010335 |
| Q2 2026Quarterly · 2025-12-31 | Segment | Protein Sciences | 215,084,000 | USD | 0001104659-26-010335 |
| Q1 2026Quarterly · 2025-09-30 | Geography | APACExcluding Greater China | 19,147,000 | USD | 0001104659-25-107053 |
| Q1 2026Quarterly · 2025-09-30 | Geography | China | 24,786,000 | USD | 0001104659-25-107053 |
| Q1 2026Quarterly · 2025-09-30 | Geography | EMEAExcluding UK | 65,128,000 | USD | 0001104659-25-107053 |
| Q1 2026Quarterly · 2025-09-30 | Geography | Rest of World | 9,049,000 | USD | 0001104659-25-107053 |
| Q1 2026Quarterly · 2025-09-30 | Geography | United Kingdom | 13,205,000 | USD | 0001104659-25-107053 |
| Q1 2026Quarterly · 2025-09-30 | Geography | United States | 155,240,000 | USD | 0001104659-25-107053 |
| Q1 2026Quarterly · 2025-09-30 | Product | Product And Services — Consumables | 231,601,000 | USD | 0001104659-25-107053 |
| Q1 2026Quarterly · 2025-09-30 | Product | Product And Services — Instruments | 21,826,000 | USD | 0001104659-25-107053 |
| Q1 2026Quarterly · 2025-09-30 | Product | Royalty | 5,646,000 | USD | 0001104659-25-107053 |
| Q1 2026Quarterly · 2025-09-30 | Product | Services | 27,482,000 | USD | 0001104659-25-107053 |
| Q1 2026Quarterly · 2025-09-30 | Segment | Diagnostics And Spatial Biology | 79,458,000 | USD | 0001104659-25-107053 |
| Q1 2026Quarterly · 2025-09-30 | Segment | Protein Sciences | 202,188,000 | USD | 0001104659-25-107053 |
| Q4 2025Quarterly · 2025-06-30 | Geography | APACExcluding Greater China | 18,886,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Geography | China | 26,905,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Geography | EMEAExcluding UK | 70,349,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Geography | Rest of World | 9,649,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Geography | United Kingdom | 14,788,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Geography | United States | 176,388,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Product | Product And Services — Consumables | 252,941,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Product | Product And Services — Instruments | 28,901,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Product | Royalty | 5,506,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Product | Services | 29,617,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Segment | Diagnostics And Spatial Biology | 89,705,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-06-30 | Segment | Protein Sciences | 226,472,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-06-30 | Geography | APACExcluding Greater China | 77,263,000 | USD | 0001558370-25-011716 |
| FY 2025Yearly · 2025-06-30 | Geography | China | 100,463,000 | USD | 0001558370-25-011716 |
| FY 2025Yearly · 2025-06-30 | Geography | EMEAExcluding UK | 266,305,000 | USD | 0001558370-25-011716 |
| FY 2025Yearly · 2025-06-30 | Geography | Rest of World | 37,547,000 | USD | 0001558370-25-011716 |
| FY 2025Yearly · 2025-06-30 | Geography | United Kingdom | 54,827,000 | USD | 0001558370-25-011716 |
| FY 2025Yearly · 2025-06-30 | Geography | United States | 683,230,000 | USD | 0001558370-25-011716 |
| FY 2025Yearly · 2025-06-30 | Product | Product And Services — Consumables | 972,286,000 | USD | 0001558370-25-011716 |
| FY 2025Yearly · 2025-06-30 | Product | Product And Services — Instruments | 112,086,000 | USD | 0001558370-25-011716 |
| FY 2025Yearly · 2025-06-30 | Product | Royalty | 23,693,000 | USD | 0001558370-25-011716 |
| FY 2025Yearly · 2025-06-30 | Product | Services | 111,570,000 | USD | 0001558370-25-011716 |
| FY 2025Yearly · 2025-06-30 | Segment | Diagnostics And Spatial Biology | 346,263,000 | USD | 0001558370-25-011716 |
| FY 2025Yearly · 2025-06-30 | Segment | Protein Sciences | 870,245,000 | USD | 0001558370-25-011716 |
| Q3 2025Quarterly · 2025-03-31 | Geography | APACExcluding Greater China | 21,245,000 | USD | 0001104659-26-056302 |
| Q3 2025Quarterly · 2025-03-31 | Geography | China | 24,483,000 | USD | 0001104659-26-056302 |
| Q3 2025Quarterly · 2025-03-31 | Geography | EMEAExcluding UK | 66,501,000 | USD | 0001104659-26-056302 |
| Q3 2025Quarterly · 2025-03-31 | Geography | Rest of World | 9,179,000 | USD | 0001104659-26-056302 |
| Q3 2025Quarterly · 2025-03-31 | Geography | United Kingdom | 12,852,000 | USD | 0001104659-26-056302 |
| Q3 2025Quarterly · 2025-03-31 | Geography | United States | 181,921,000 | USD | 0001104659-26-056302 |
| Q3 2025Quarterly · 2025-03-31 | Product | Other | 737,000 | USD | 0001104659-26-056302 |
| Q3 2025Quarterly · 2025-03-31 | Product | Product And Services — Consumables | 257,785,000 | USD | 0001104659-26-056302 |
| Q3 2025Quarterly · 2025-03-31 | Product | Product And Services — Instruments | 26,111,000 | USD | 0001104659-26-056302 |
| Q3 2025Quarterly · 2025-03-31 | Product | Royalty | 5,039,000 | USD | 0001104659-26-056302 |
| Q3 2025Quarterly · 2025-03-31 | Product | Services | 27,246,000 | USD | 0001104659-26-056302 |
| Q3 2025Quarterly · 2025-03-31 | Segment | Diagnostics And Spatial Biology | 89,231,000 | USD | 0001104659-26-056302 |
| Q3 2025Quarterly · 2025-03-31 | Segment | Protein Sciences | 227,687,000 | USD | 0001104659-26-056302 |
| Q2 2025Quarterly · 2024-12-31 | Geography | APACExcluding Greater China | 19,010,000 | USD | 0001104659-26-010335 |
| Q2 2025Quarterly · 2024-12-31 | Geography | China | 24,754,000 | USD | 0001104659-26-010335 |
| Q2 2025Quarterly · 2024-12-31 | Geography | EMEAExcluding UK | 70,392,000 | USD | 0001104659-26-010335 |
| Q2 2025Quarterly · 2024-12-31 | Geography | Rest of World | 9,726,000 | USD | 0001104659-26-010335 |
| Q2 2025Quarterly · 2024-12-31 | Geography | United Kingdom | 13,243,000 | USD | 0001104659-26-010335 |
| Q2 2025Quarterly · 2024-12-31 | Geography | United States | 159,906,000 | USD | 0001104659-26-010335 |
| Q2 2025Quarterly · 2024-12-31 | Product | Product And Services — Consumables | 230,715,000 | USD | 0001104659-26-010335 |
| Q2 2025Quarterly · 2024-12-31 | Product | Product And Services — Instruments | 30,868,000 | USD | 0001104659-26-010335 |
| Q2 2025Quarterly · 2024-12-31 | Product | Royalty | 8,098,000 | USD | 0001104659-26-010335 |
| Q2 2025Quarterly · 2024-12-31 | Product | Services | 27,350,000 | USD | 0001104659-26-010335 |
| Q2 2025Quarterly · 2024-12-31 | Segment | Diagnostics And Spatial Biology | 84,135,000 | USD | 0001558370-25-000689 |
| Q2 2025Quarterly · 2024-12-31 | Segment | Other Revenues From Business Held For Sale | 1,849,000 | USD | 0001558370-25-000689 |
| Q2 2025Quarterly · 2024-12-31 | Segment | Protein Sciences | 211,551,000 | USD | 0001558370-25-000689 |
| Q1 2025Quarterly · 2024-09-30 | Geography | APACExcluding Greater China | 18,122,000 | USD | 0001104659-25-107053 |
| Q1 2025Quarterly · 2024-09-30 | Geography | China | 24,321,000 | USD | 0001104659-25-107053 |
| Q1 2025Quarterly · 2024-09-30 | Geography | EMEAExcluding UK | 59,063,000 | USD | 0001104659-25-107053 |
| Q1 2025Quarterly · 2024-09-30 | Geography | Rest of World | 8,993,000 | USD | 0001104659-25-107053 |
| Q1 2025Quarterly · 2024-09-30 | Geography | United Kingdom | 13,944,000 | USD | 0001104659-25-107053 |
| Q1 2025Quarterly · 2024-09-30 | Geography | United States | 165,015,000 | USD | 0001104659-25-107053 |
| Q1 2025Quarterly · 2024-09-30 | Product | Product And Services — Consumables | 230,845,000 | USD | 0001104659-25-107053 |
| Q1 2025Quarterly · 2024-09-30 | Product | Product And Services — Instruments | 26,206,000 | USD | 0001104659-25-107053 |
| Q1 2025Quarterly · 2024-09-30 | Product | Royalty | 5,050,000 | USD | 0001104659-25-107053 |
| Q1 2025Quarterly · 2024-09-30 | Product | Services | 27,357,000 | USD | 0001104659-25-107053 |
| Q1 2025Quarterly · 2024-09-30 | Segment | Diagnostics And Spatial Biology | 83,192,000 | USD | 0001558370-24-014439 |
| Q1 2025Quarterly · 2024-09-30 | Segment | Other Revenues From Business Held For Sale | 2,303,000 | USD | 0001558370-24-014439 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.